| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
HDLLDLLXRCETPApolipoprotein AIEndothelial lipaseDoxazosinRegeneration of tissues and other biologic structuresABCA1NiacinReceptor (Pregnane X Receptor)ABCG1Acute phase reactionSphingosine1 phosphateThrombosis (BASKET)StatinRosuvastatinSimvastatinAtorvastatinAtherosclerosis (peripheral vessels)Phospholipid transfer proteinParaoxonase1Serum Amyloid AInflammation (BASKET)Lipoprotein associated phospholipase A2sPLA2Receptor (Scavenger)Receptor (S1P)Antigen presentation and processing| 1 | 2008 | High-density lipoproteins: the next frontier in lipid management. | 
| + | - | nl | Med J Aust 189(8):421-2 (2008) |
| 2 | 2007 | Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets. | 
| + | - | nl | Heart 93(5):559-64 (2007) |
| 3 | 2008 | High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease. | 
| + | - | nl | Vasc Health Risk Manag 4(1):39-57 (2008) |
| 4 | 2005 | Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium. | 
| + | - | nl | Vasc Health Risk Manag 1(2):119-29 (2005) |
| 5 | 2006 | Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. | 
| + | - | nl | Pharmacol Rev 58(3):342-74 (2006) |
| 6 | 2008 | HDL-C as a new paradigm in atherosclerotic diseases. | 
| + | - | nl | Indian J Physiol Pharmacol 52(4):319-26 (2008) |
| 7 | 2006 | High-density lipoproteins: an emerging target in the prevention of cardiovascular disease. | 
| + | - | nl | Cell Res 16(10):799-808 (2006) |
| 8 | 2009 | Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications. | 
| + | - | nl | BMB Rep 42(7):393-400 (2009) |
| 9 | 2008 | High-density lipoprotein: does it have a dark side? | 
| + | - | nl | Arthritis Res Ther 10(5):121 (2008) |
| 10 | 2008 | Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. | 
| + | - | nl | Arthritis Res Ther 10(4):213 (2008) |
| 11 | 2001 | Oxidized LDL and HDL: antagonists in atherothrombosis. | 
| + | - | nl | FASEB J 15(12):2073-84 (2001) |
| 12 | 2007 | The structure of apolipoprotein A-I in high density lipoproteins. | 
| + | - | nl | J Biol Chem 282(31):22249-53 (2007) |
| 13 | 2006 | Assembly of high-density lipoprotein. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 26(1):20-7 (2006) |
| 14 | 2004 | High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 24(3):387-91 (2004) Brewer HB Jr |
| 15 | 2003 | Endothelial protection by high-density lipoproteins: from bench to bedside. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 23(10):1724-31 (2003) |
| 16 | 2004 | Antiinflammatory properties of HDL. | 
| + | - | nl | Circ Res 95(8):764-72 (2004) |
| 17 | 2003 | Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data. | 
| + | - | nl | Diabetes Metab 29(3):201-5 (2003) |
| 18 | 2006 | Molecular regulation of HDL metabolism and function: implications for novel therapies. | 
| + | - | nl | J Clin Invest 116(12):3090-100 (2006) |
| 19 | 1990 | Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. | 
| + | - | nl | J Clin Invest 86(2):379-84 (1990) |
| 20 | 2007 | HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. | 
| + | - | nl | J Lipid Res 48(11):2325-33 (2007) |
| 21 | 2006 | Thematic review series: patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans? | 
| + | - | nl | J Lipid Res 47(8):1631-42 (2006) |
| 22 | 2004 | The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. | 
| + | - | nl | J Lipid Res 45(6):993-1007 (2004) |
| 23 | 1999 | High density lipoprotein receptors, binding proteins, and ligands. | 
| + | - | nl | J Lipid Res 40(2):187-201 (1999) |
| 24 | 1984 | Synthesis, transport, and processing of apolipoproteins of high density lipoproteins. | 
| + | - | nl | J Lipid Res 25(13):1586-92 (1984) |
| 25 | 1984 | Sites and mechanisms of uptake and degradation of high density and low density lipoproteins. | 
| + | - | nl | J Lipid Res 25(13):1577-85 (1984) |
| 26 | 1984 | High density lipoprotein metabolism. | 
| + | - | nl | J Lipid Res 25(10):1017-58 (1984) |
| 27 | 2007 | High-density lipoprotein as a therapeutic target: a systematic review. | 
| + | - | nl | JAMA 298(7):786-98 (2007) |
| 28 | 2009 | From menace to marvel: high-density lipoprotein prevents endothelial nitric oxide synthase uncoupling in diabetes mellitus by angiotensin II type 1 receptor downregulation. | 
| + | - | nl | Hypertension 53(4):587-9 (2009) |
| 29 | 2006 | Liver X receptor activation and high-density lipoprotein biology: a reversal of fortune? | 
| + | - | nl | Circulation 113(1):5-8 (2006) Lee CH |
| 30 | 2010 | The complexity of high-density lipoproteins. | 
| + | - | nl | Circulation 122(19):1900-1 (2010) |
| 31 | 2005 | Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians. | 
| + | - | nl | Circulation 111(14):1847-54 (2005) |
| 32 | 2011 | Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. | 
| + | - | nl | Circ J 75(7):1533-8 (2011) |
| 33 | 2010 | Update on the role of endothelial lipase in high-density lipoprotein metabolism, reverse cholesterol transport, and atherosclerosis. | 
| + | - | nl | Circ J 74(11):2263-70 (2010) |
| 34 | 2007 | Old drug, new tricks: the unexpected effect of doxazosin on high-density lipoprotein. | 
| + | - | nl | Circ Res 101(2):116-8 (2007) Remaley AT |
| 35 | 2005 | New insights into the regulation of HDL metabolism and reverse cholesterol transport. | 
| + | - | nl | Circ Res 96(12):1221-32 (2005) |
| 36 | 2006 | Endothelial and antithrombotic actions of HDL. | 
| + | - | nl | Circ Res 98(11):1352-64 (2006) |
| 37 | 2010 | High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 30(8):1497-9 (2010) Getz GS |
| 38 | 2006 | A new dimension in the vasculoprotective function of HDL: progenitor-mediated endothelium repair. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 26(5):965-7 (2006) Lesnik P |
| 39 | 2004 | Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 24(10):1755-60 (2004) |
| 40 | 2008 | Antiinflammatory actions of HDL: a new insight. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 28(11):1890-1 (2008) Rye KA |
| 41 | 2008 | Of mice and men: blowing away the cobwebs from the mechanism of action of niacin on HDL metabolism. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 28(11):1892-5 (2008) Watts GF |
| 42 | 2010 | Structure and function of HDL mimetics. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 30(2):164-8 (2010) |
| 43 | 2010 | Dysfunctional HDL as a diagnostic and therapeutic target. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 30(2):151-5 (2010) |
| 44 | 2005 | A role for the pregnane X receptor in high-density lipoprotein metabolism. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 25(10):2016-7 (2005) Shelness GS |
| 45 | 2005 | Cardioprotective effects of high-density lipoproteins: the evidence strengthens. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 25(7):1305-6 (2005) Barter PJ |
| 46 | 2009 | The molecular mechanisms of HDL and associated vesicular trafficking mechanisms to mediate cellular lipid homeostasis. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 29(11):1718-22 (2009) |
| 47 | 2010 | Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 30(2):139-43 (2010) |
| 48 | 2006 | Understanding changes in high density lipoproteins during the acute phase response. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 26(8):1687-8 (2006) Van Lenten BJ |
| 49 | 2009 | Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. | 
| + | - | nl | Cardiovasc Res 82(2):201-11 (2009) |
| 50 | 2008 | High-density lipoprotein mass, cholesteryl ester transport protein, and macrophage reverse cholesterol transport: from the bedside back to the bench. | 
| + | - | nl | Cardiovasc Res 77(4):614-5 (2008) Levy Y |
| 51 | 2002 | The role of high density lipoproteins in thrombosis. | 
| + | - | nl | ScientificWorldJournal 2(-):89-95 (2002) |
| 52 | 2005 | Strategies to promote HDL-C: an emerging therapeutic target. | 
| + | - | nl | Eur Heart J 26(9):853-5 (2005) |
| 53 | 2010 | Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database. | 
| + | - | nl | J Lipid Res 51(6):1546-53 (2010) |
| 54 | 2010 | Genetic causes of high and low serum HDL-cholesterol. | 
| + | - | nl | J Lipid Res 51(8):2032-57 (2010) |
| 55 | 2010 | The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? | 
| + | - | nl | J Lipid Res 51(8):2058-73 (2010) |
| 56 | 2009 | The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis. | 
| + | - | nl | J Lipid Res 50 Suppl(-):S201-6 (2009) |
| 57 | 2009 | The metabolism and anti-atherogenic properties of HDL. | 
| + | - | nl | J Lipid Res 50 Suppl(-):S195-200 (2009) |
| 58 | 2005 | Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? | 
| + | - | nl | J Lipid Res 46(3):389-403 (2005) |
| 59 | 2009 | The role of dysfunctional HDL in atherosclerosis. | 
| + | - | nl | J Lipid Res 50 Suppl(-):S145-9 (2009) |
| 60 | 2009 | Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma. | 
| + | - | nl | J Clin Endocrinol Metab 94(4):1081-3 (2009) Fazio S |
| 61 | 2009 | Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I. | 
| + | - | nl | Endocr J 56(3):317-34 (2009) |
| 62 | 2008 | Laboratory assessment of HDL heterogeneity and function. | 
| + | - | nl | Clin Chem 54(5):788-800 (2008) |
| 63 | 2007 | Therapies for raising high-density lipoprotein cholesterol. | 
| + | - | nl | Intern Med 46(7):339-40 (2007) |
| 64 | 2006 | High-density lipoproteins: metabolic, clinical, epidemiological and therapeutic intervention aspects. An update for clinicians. | 
| + | - | nl | Arq Bras Cardiol 87(5):671-9 (2006) |
| 65 | 2006 | HDL management: recent advances and perspectives beyond LDL reduction. | 
| + | - | nl | Arq Bras Cardiol 87(6):788-94 (2006) |
| 66 | 2010 | Increasing high-density lipoprotein as a therapeutic target in atherothrombotic disease. | 
| + | - | nl | Rev Esp Cardiol 63(3):323-33 (2010) |
| 67 | 2010 | High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy. | 
| + | - | nl | Clin Exp Immunol 160(2):137-42 (2010) |